Axsome Therapeutics, Inc. short interest in 2026
In 2026, Axsome Therapeutics, Inc.'s disclosed short interest ran from 5.38% of shares outstanding on 15 Jan 2026 to 5.99% on 15 Sep 2026, a change of +0.61 percentage points. The year's high was 6.62% on 31 Jul 2026 and its low 5.12% on 30 Jun 2026, averaging 5.67% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.83 days on 31 Aug 2026. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 5.38% (15 Jan 2026)
- End of year
- 5.99% (15 Sep 2026)
- Change
- +0.61 pp
- High
- 6.62% (31 Jul 2026)
- Low
- 5.12% (30 Jun 2026)
- Average
- 5.67%
- Highest days to cover
- 5.83 (31 Aug 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 5.38% | 3.19 | results (8-K) |
| 30 Jan 2026 | 5.38% | 4.06 | |
| 13 Feb 2026 | 5.38% | 5.06 | |
| 27 Feb 2026 | 5.15% | 4.11 | 10-K filed, results (8-K) |
| 13 Mar 2026 | 5.48% | 4.97 | |
| 31 Mar 2026 | 5.61% | 4.89 | |
| 15 Apr 2026 | 5.31% | 4.55 | |
| 30 Apr 2026 | 5.34% | 3.37 | |
| 15 May 2026 | 5.40% | 2.93 | 10-Q filed, results (8-K) |
| 29 May 2026 | 6.01% | 4.99 | |
| 15 Jun 2026 | 6.38% | 4.80 | |
| 30 Jun 2026 | 5.12% | 1.61 | |
| 15 Jul 2026 | 5.88% | 3.78 | |
| 31 Jul 2026 | 6.62% | 5.11 | |
| 14 Aug 2026 | 6.12% | 3.98 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 5.88% | 5.83 | |
| 15 Sep 2026 | 5.99% | 5.19 |
See also: Axsome Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.